Home > Insider Trading > Filing (0001209191-21-007906)

Filing Details

Accession Number:: 0001209191-21-007906
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-04 19:58:03
Reporting Period:: 2021-02-02

Accepted Time:: 2021-02-04 19:58:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1396814	Pacira Biosciences Inc.	PCRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1204788	M David Stack	C/O Pacira Biosciences, Inc. 5 Sylvan Way, Suite 300 Parsippany NJ 07054	Ceo And Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-02	21,250	$10.81	97,311	No	4	M	Direct
Common Stock	Disposition	2021-02-02	2,900	$68.41	94,411	No	4	S	Direct
Common Stock	Disposition	2021-02-02	14,250	$69.38	80,161	No	4	S	Direct
Common Stock	Disposition	2021-02-02	4,100	$70.20	76,061	No	4	S	Direct
Common Stock	Acquisiton	2021-02-03	21,250	$10.81	97,311	No	4	M	Direct
Common Stock	Disposition	2021-02-03	6,900	$70.78	90,411	No	4	S	Direct
Common Stock	Disposition	2021-02-03	14,350	$71.42	76,061	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-02-02	21,250	$0.00	21,250	$10.81
Common Stock	Stock Option (Right to Buy)	Disposition	2021-02-03	21,250	$0.00	21,250	$10.81

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
152,420		2022-06-05	No	4	M	Direct
131,170		2022-06-05	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	98,353	Indirect	By Three Colleens Investment, LLC
Common Stock	18,596	Indirect	By Stack Schroon Mohawk FLP
Common Stock	315	Indirect	By LCK Investment LLC

Footnotes

The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Includes 144 shares of common stock acquired under the issuer's employee stock purchase plan in December 2020.
Reflects the transfer of 98,353 shares of common stock previously held directly by the reporting person to Three Colleens Investment, LLC, an entity through which the reporting person holds such shares of common stock indirectly.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.83 to $68.82, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 through 8.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.83 to $69.815, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.83 to $70.795, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.99 to $70.985, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.99 to $71.85, inclusive.
Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.